Stocklytics Platform
Asset logo for symbol TSVT
2seventy bio
TSVT65
$4.99arrow_drop_down0.10%-$0.00
Penny Stock
Asset logo for symbol TSVT
TSVT65

$4.99

arrow_drop_down0.10%

Income Statement (TSVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$13.43M-$19.92M-$48.65M-$59.88M-$36.52M
EBITDA-$11.78M-$18.24M-$46.54M-$56.85M-$33.75M
gross Profit$7.76M$5.51M$5.82M$4.50M$7.07M
NET Income-$9.93M$24.87M-$52.67M-$56.82M-$71.63M
total Revenue$13.53M$8.96M$12.43M$10.68M$12.03M

Balance Sheet (TSVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt$187.46M$139.53M$196.28M$181.71M$169.93M
stockholders Equity$228.10M$234.80M$207.43M$255.30M$306.42M
total Assets$503.84M$517.89M$511.05M$565.42M$640.80M
total Debt$247.44M$251.39M$253.07M$256.67M$260.15M
total Liabilities$275.74M$283.09M$303.61M$310.12M$334.38M

Cash Flow (TSVT)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$52.00K-$24.00K$386.00K$253.00K-$75.00K
free Cash Flow-$10.53M-$23.20M-$42.48M-$64.66M-$24.25M
investing Cash Flow-----
operating Cash Flow-$10.50M-$23.14M-$41.87M-$63.59M-$21.51M

2seventy bio (TSVT) Financials

2seventy bio, Inc. (TSVT) is a biotechnology company focused on developing innovative medical solutions. The company's financials reflect its strong performance in the industry. According to the income statement, 2seventy bio, Inc. has generated impressive total revenue. The gross profit indicates the company's ability to efficiently manage its operations and control costs. Additionally, the EBIT and EBITDA figures demonstrate the company's profitability and financial stability. The net income from stockholders highlights the company's success in providing returns to its investors.
On the balance sheet, 2seventy bio, Inc. shows a healthy stockholders equity, indicating a strong financial position. The total assets of the company signify its substantial resources and potential for growth. Moreover, the company has effectively managed its total debt and liabilities, ensuring a secure financial structure. The cash equivalents provide liquidity and flexibility to the company, enabling it to pursue strategic opportunities. Furthermore, the cash flow statement demonstrates the company's sound financial management, with positive operating, investing, and financing cash flows. The free cash flow indicates the company's ability to generate excess cash for future investments.
add 2seventy bio to watchlist

Keep an eye on 2seventy bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level